HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN


FDA approves Myfembree for endometriosis pain

August 05, 2022

Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.

MRI to diagnose endometriosis

June 17, 2022

A review of magnetic resonance imaging (MRI) for diagnosing endometriosis and related diseases in the Korean Journal of Radiology has found that the medical imaging technique can help in the early and accurate diagnosis of ovarian endometriotic cysts and deep infiltrating endometriosis (DIE), while avoiding the need for invasive procedures and radiation exposure, due to MRI’s high contrast and objectivity.

Is body fat linked to endometriosis?

May 18, 2022

Rates of endometriosis are generally higher in leaner women, yet there still seems to be a connection between the presence and placement of fat tissue and the development of endometriosis. One study team sought to find out why.

Transcutaneous electrical neurostimulation for dysmenorrhea

May 17, 2022

A preprogrammed, nomad, easy-to-use, transcutaneous electrical nerve stimulation (TENS) device was well tolerated and provided rapid and lasting pain decrease in women with primary dysmenorrhea (PD), according to a study published in the journal Progrés en Urologie.